ReviewFrontiers in immunology2017

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Michael J E Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.